Drupal.behaviors.print = function(context) {window.print();window.close();}>
GE Healthcare to Invest $1B in Cancer R&D Including Biomarker Development
September 15, 2011
GE Healthcare to Invest $1B in Cancer R&D Including Biomarker Development
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
GE Healthcare to Acquire Clarient for $580M
October 22, 2010 / GenomeWeb Daily News
Clarient, Acorn Team Up on Tumor Molecular Testing
December 9, 2011 / GenomeWeb Daily News
Clarient to Sell CombiMatrix's DNAarray Products
April 11, 2011 / GenomeWeb Daily News
GE Healthcare Completes Tender Offer for Clarient
December 23, 2010 / GenomeWeb Daily News
Clarient Shareholders Tender 80 Percent of Shares in GE Healthcare Acquisition
December 17, 2010 / GenomeWeb Daily News